PNC27

Healing

$180.00

What it is

PNC-27 is a laboratory-engineered peptide that combines:

  • A segment from the HDM-2 binding domain of p53

  • A membrane-penetrating peptide sequence that helps it enter cells

Its design allows it to selectively interact with cancer cells.

Proposed Mechanism of Action

PNC-27 is intended to:

  1. Bind to HDM2 (also known as MDM2), a protein often overexpressed on the surface of certain cancer cells.

  2. Form pores in the cancer cell membrane.

  3. Trigger rapid necrosis (cell death) without significantly affecting normal cells in laboratory studies.

Unlike many cancer therapies that induce apoptosis (programmed cell death), PNC-27 has been reported in preclinical research to cause direct membrane disruption.

Research Status

  • Studied primarily in in vitro (cell culture) and animal models.

  • Not approved by the FDA or any major regulatory agency.

  • No established clinical trials confirming safety or efficacy in humans.

Important Notes

  • PNC-27 is considered experimental.

  • It is not an approved cancer treatment.

  • Safety, dosing, long-term effects, and real-world effectiveness remain unproven.

If you’d like, I can also explain how it compares to other p53-related therapeutic strategies.